# Toyobo Co. Ltd. – FDA Inspection, Feb 25, 2021

Source: https://www.keypedia.com/records/fda_inspections/toyobo-co-ltd/36cc0553-d11a-4789-8319-10ff0581dd88
Source feed: FDA_Inspections

> FDA inspection 1136484 of Toyobo Co. Ltd., February 25, 2021. Classification: Official Action Indicated (OAI). 11 citations under 21 CFR part 211. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1136484
- Company Name: Toyobo Co. Ltd.
- Inspection Date: 2021-02-25
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 11
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1201609 - 2023-02-25](https://www.keypedia.com/records/fda_inspections/toyobo-co-ltd/9343d674-344f-46c6-b87d-55382e6aea3b)
- [FDA Inspection 1100505 - 2019-07-30](https://www.keypedia.com/records/fda_inspections/toyobo-co-ltd/4a1dae20-d436-4929-8e5b-caee58d1a841)
- [FDA Inspection 1039008 - 2018-01-23](https://www.keypedia.com/records/fda_inspections/toyobo-co-ltd/20f75836-43b2-4455-8857-f52e97e4f174)

Company: https://www.keypedia.com/companies/toyobo-co-ltd/f6d8fe5d-b154-45db-bff8-bd0be01d2fa9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
